Is the Answer in the Biopsy? Predicting 12-Month RRT Outcomes in Renal Thrombotic Microangiopathy
Year: 2026
Type: article
Study design: Observational Study
Abstract: The prognostic value of quantitatively assessed histologic lesions in biopsy-proven renal thrombotic microangiopathy (TMA) remains poorly defined. We retrospectively evaluated 37 adults with biopsy-proven renal TMA to identify clinical and histologic predictors of renal replacement therapy (RRT) dependence at 12 months. At presentation, 18 patients (48.6%) required RRT, and 17 (45.9%) remained RRT-dependent at 12 months. Patients with persistent RRT dependence had higher peak serum creatinine (sCr) (8.97 ± 3.91 vs. 4.78 ± 2.20 mg/dL; p < 0.001) and greater proteinuria at diagnosis (5828 vs. 1365 mg/g; p = 0.004). Peak sCr showed the strongest discrimination for 12-month RRT dependence (AUC 0.815; cutoff 7.6 mg/dL). Among histologic variables, global glomerulosclerosis showed the best discrimination (AUC 0.725; cutoff ≥ 8%), whereas other TMA-associated lesions had limited prognostic value. In multivariable analysis, both peak sCr (OR 1.74, 95% CI 1.16–2.62; p = 0.008) and global glomerulosclerosis ≥ 8% (OR 8.76, 95% CI 1.23–62.40; p = 0.030) were independently associated with 12-month RRT dependence. Adding global glomerulosclerosis ≥ 8% significantly improved model fit compared with peak sCr alone (likelihood-ratio test, p = 0.016), increasing the apparent AUC from 0.815 to 0.868.
Authors: Marc Patricio-Liébana(Conceptualization, Data curation, Formal analysis, Investigation, Software, Writing – original draft), Natàlia Ramos, Alejandra Gabaldón, Zaira Castañeda(Conceptualization, Investigation, Writing – review & editing), Sheila Bermejo(Writing – review & editing), Juan León-Román(Writing – review & editing), Néstor Toapanta(Writing – review & editing), María A. Azancot, Sara Núñez, Marina López(Writing – review & editing), Irene Agraz(Writing – review & editing), Oriol Bestard(Writing – review & editing), María José Soler
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7234920266
